NCT02523040 2025-12-10Lenalidomide for Adult Histiocyte DisordersDana-Farber Cancer InstitutePhase 2 Active not recruiting12 enrolled 14 charts
NCT01057121 2022-02-08Lenalidomide in Treating Patients With AIDS-Associated Kaposi's SarcomaNational Cancer Institute (NCI)Phase 1/2 Completed38 enrolled 11 charts